Use of Bacteriophages to Prevent, Diagnose, and Treat Diseases
$1,016,952ZIAFY2025CANIH
Division Of Basic Sciences - Nci
Investigators
Linked publications, trials & patents
Paper 33622728Paper 32001571Paper 31992617Paper 31185183Paper 30782818Paper 28096488Paper 24384811Paper 22733746Paper 18179417Paper 16549760Paper 16085886Paper 16055223Paper 16040799Paper 15720541Paper 14729334Paper 14607116Paper 12776223Patent 7410801
Abstract
The extracellular domain of EGFRvIII was displayed on Lambda virion by genetic fusion of the EGFRvII peptide to Lambda head protein D. Upon administration of the this Lambda virion into experimental mice, it generated mice serum which specifically interct with EGFRvIII protein but not with wildtype EGFR . The serum The specificity tests were performed by ELISA assays and Western Blot experiments. These results provide strong evidence that our EGFRvIII phage display system has high potential to act as vaccines in EGFRvIII cancers. We would like to follow tumor regression in mouse models with experimental EGFRviii Glioblastoma using the phage-based potential EGFRvIII vaccine
View original record on NIH RePORTER →